In the extended Danish study population, a dramatic 60% reduction in overall BC and ductal BC risks were identified in Thr carriers for rs3877899 (Ala234Thr) in SEPP1 (Table 2), suggesting a key role of the Se transporter in the aetiology of the disease and/or breast tissue function [35]. This evidence concerns the gene SELENOP and breast cancer.